Related Experiment Video
Updated: May 9, 2026

Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients
Published on: June 24, 2019
Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia
Dimitrios S Karagiannakis1, Jiannis Vlachogiannakos, Georgios Anastasiadis
1Hepatogastroenterology Unit, 1st Department of Medicine Propaedeutic, Medical School of Athens, Laikon General Hospital, 17 Agiou Thoma Street, 11527, Athens, Greece, d_karagiannakis@hotmail.com.
Insights
Cirrhotic cardiomyopathy, a cardiac dysfunction in cirrhosis patients, is often linked to bacterial endotoxemia. Higher lipopolysaccharide-binding protein (LBP) levels correlate with diastolic dysfunction severity in these patients.
Area of Science:
- Cardiology
- Gastroenterology
- Internal Medicine
Background:
- Cirrhotic cardiomyopathy is a known cardiac dysfunction in liver cirrhosis.
- Its exact pathogenesis remains incompletely understood.
- Bacterial endotoxemia is a potential contributing factor.
Purpose of the Study:
- To determine the frequency and characteristics of cirrhotic cardiomyopathy.
- To investigate the role of bacterial endotoxemia in worsening this condition.
Main Methods:
- Echocardiography (tissue Doppler imaging) was used to assess cardiac function in 45 cirrhotic patients.
- Diastolic dysfunction was diagnosed and graded using established guidelines.
- Serum levels of lipopolysaccharide-binding protein (LBP) and cytokines were measured to estimate endotoxemia.
Main Results:
- Diastolic dysfunction was present in 37.8% of patients; no systolic dysfunction was observed.
- Patients with grade II diastolic dysfunction showed significantly higher QTc, left atrium volume, Brain Natriuretic Peptide, and LBP levels.
- The severity of diastolic dysfunction correlated significantly with LBP levels, which were independently associated with diastolic dysfunction.
Conclusions:
- Cardiac dysfunction is common in cirrhosis.
- Elevated LBP levels are associated with severe cirrhotic cardiomyopathy and diastolic dysfunction.
- Bacterial endotoxemia may play a role in aggravating cardiomyopathy in cirrhotic patients.
Background:
The cardiac dysfunction presented in cirrhotic patients is already known as cirrhotic cardiomyopathy. The pathogenesis of this entity is not fully understood.
Aims:
The aim of this study was to evaluate the frequency and characteristics of cirrhotic cardiomyopathy and to investigate the possible role of bacterial endotoxemia on its aggravation.
Methods:
Forty-five cirrhotics were studied by a tissue Doppler imaging echocardiography at rest and after stress. The diagnosis of left ventricular diastolic dysfunction was based on the latest guidelines of the American Society of Echocardiography, whereas its severity was defined by the E/e'av ratio. Endotoxemia was estimated by measuring the serum levels of lipopolysaccharide-binding protein (LBP) and cytokines.
Results:
None of the patients had systolic dysfunction, but 17/45 (37.8 %) had a diastolic one. Patients with grade II diastolic dysfunction had significantly longer QTc (p = 0.049), larger left atrium volume (p = 0.013), higher Brain Natriuretic Peptide levels (p = 0.007) and higher LBP levels (p = 0.02), compared to those with normal cardiac function, without differences in the systemic hemodynamics and the cytokines' levels. Moreover, the severity of diastolic dysfunction as reflected by the E/e'av. was significantly correlated with the LBP levels (p = 0.002). On the multivariate analysis, the LBP was independently associated with the presence of diastolic dysfunction.
Conclusions:
Cirrhosis is commonly complicated by cardiac dysfunction. Patients with severe cirrhotic cardiomyopathy have higher LBP levels, which are significantly correlated with the degree of diastolic dysfunction. Our findings support a potential role of bacterial endotoxemia on the aggravation of cardiomyopathy in cirrhotic patients.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management